GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ceapro Inc (OTCPK:CRPOF) » Definitions » Profitability Rank

Ceapro (Ceapro) Profitability Rank : 6 (As of Dec. 2023)


View and export this data going back to 1992. Start your Free Trial

What is Ceapro Profitability Rank?

Ceapro has the Profitability Rank of 6.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

Ceapro's Operating Margin % for the quarter that ended in Dec. 2023 was -167.91%. As of today, Ceapro's Piotroski F-Score is 3.


Competitive Comparison of Ceapro's Profitability Rank

For the Biotechnology subindustry, Ceapro's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ceapro's Profitability Rank Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ceapro's Profitability Rank distribution charts can be found below:

* The bar in red indicates where Ceapro's Profitability Rank falls into.



Ceapro Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Ceapro has the Profitability Rank of 6.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Ceapro's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as:

Operating Margin %=Operating Income (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=-2.067 / 1.231
=-167.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

Ceapro has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

4. Consistency of the profitability

5. Predictability Rank


Ceapro Profitability Rank Related Terms

Thank you for viewing the detailed overview of Ceapro's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Ceapro (Ceapro) Business Description

Traded in Other Exchanges
Address
7824-51 Avenue NW, Edmonton, AB, CAN, T6E 6W2
Ceapro Inc is engaged in the development and marketing of various health and wellness products and technology relating to plant extracts. Its operating segment is the active ingredient product technology industry which involves the development of proprietary extraction technologies and the application of these technologies to the production and development and commercialization of active ingredients derived from oats and other renewable plant resources for healthcare and cosmetic industries. Active ingredients produced include oat beta glucan and avenanthramides. The group derives revenue from the U.S., Germany, China, Canada and other countries, of which prime revenue is generated from the U.S.

Ceapro (Ceapro) Headlines

From GuruFocus

Ceapro Announces Results of 2023 Shareholders' Meeting

By sperokesalga sperokesalga 06-07-2023

Ceapro Inc. Recognized as a Top 50 TSX Venture Exchange Company

By sperokesalga sperokesalga 02-21-2023